Enabling the Nervous System to Repair Itself

Mike Kelly, CEO of NervGen Pharma, discusses the potential for using therapies designed to allow the nervous system to repair itself, how the company’s lead experimental candidate for spinal cord injury works, and why the same approach holds promise in treating a range of neurodegenerative diseases.